GSK3858279
Sponsors
GlaxoSmithKline
Conditions
Osteoarthritis, KneePain
Phase 1
Effects of Intravenous GSK3858279 on a Battery of Evoked Pain Tests in Healthy Volunteers
TerminatedNCT04114656
Start: 2019-10-15End: 2021-09-16Updated: 2024-03-18
Safety, Tolerability, Pharmacokinetics and Target Engagement of GSK3858279 in Healthy Caucasian, Chinese and Japanese Participants
CompletedNCT05174013
Start: 2022-02-14End: 2023-04-17Updated: 2025-05-15
Phase 2
A Study to Evaluate Efficacy and Safety of GSK3858279 in Diabetic Peripheral Neuropathic Pain
TerminatedNCT05838755
Start: 2023-09-20End: 2025-02-17Updated: 2025-11-21
A Dose-Finding Study to Evaluate the Efficacy and Safety of GSK3858279 in Adults With Knee Osteoarthritis (OA) Pain
TerminatedNCT05838742
Start: 2023-09-13End: 2024-12-03Updated: 2025-11-10